✦ LIBER ✦

Comparison of the immunogenicity of reduced doses of two recombinant dna hepatitis b vaccines in New Zealand children

✍ Scribed by A. Milne; T. A. Brawner; P. C. Dumbill; I. Kawachi; N. E. Pearce

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 394 KB
Volume: 27
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.1890270314

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of low doses of hepatitis

Immunogenicity of low doses of hepatitis B vaccine in children: A study in 650 New Zealand children

✍ Alexander Milne; Mary Dimitrakakis; Geoffrey Allwood; Ron Lucas; Chris Moyes; Ne 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Six hundred and fifty New Zealand children from 2-12 years of age were vaccinated three times with 2 mcg intramuscular (IM) doses of Merck Sharp and Dohme plasma-derived hepatitis B vaccine (H-B-Vax), at 0, 1, and 6 months, and tested 2-3 months later for antibody to hepatitis B surface antigen (ant

Immunogenic effect of hepatitis B vaccin

Immunogenic effect of hepatitis B vaccine in children: Comparison of two-and three-dose protocols

✍ Bernard Yvonnet; Pierre Coursaget; Eric Petat; Eric Tortey; Cheikh Diouf; Franci 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

The immunogenic effect of hepatitis B vaccine was evaluated in 183 seronegative infants from Senegal. Seventy-two seronegative infants received two 5-micrograms doses of vaccine at a two-month interval and 111 seronegative infants received three 5-micrograms doses at one-month intervals. All the chi

Immunogenicity of a yeast-recombinant he

Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children

✍ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta

Twelve-year follow-up of a prospective r

Twelve-year follow-up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children

✍ Man-Fung Yuen; Wei-Ling Lim; Chi-Chung Cheng; Shiu-Kam Lam; Ching-Lung Lai 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

A total of 318 children were prospectively randomized in group 1 with two 5-g doses of recombinant vaccine given at 0 and 1 month; in group 2 with three 5-g doses of recombinant vaccine given at 0, 1, and 6 months; or in group 3 with three doses of plasma-derived vaccine given at 0, 1, and 6 months.

Field evaluation of the efficacy and imm

Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants

✍ Alexander Milne; David J. West; Dang Van Chinh; Chris D. Moyes; Gabriele Poersch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract A study involving more than 2,000 infants was conducted in Vietnam to assess the field effectiveness and immunogenicity of recombinant hepatitis B vaccine given at birth, 1 month, 2 months, without concomitant hepatitis B immune globulin (HBIG). All received a 5 μg dose of H‐B‐VAX™II at

A placebo-controlled dose response study

A placebo-controlled dose response study of the reactogenicity and immunogenicity of a live cold-recombinant influenza B virus vaccine in healthy volunteers

✍ Dr. U. Ganzinger; H. Bachmayer; E. Liehl; J. J. Martindale; F. Hamilton; Dr. E. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A live cold-recombinant influenza B virus vaccine (RB77) was given intranasally in a placebo-controlled, double blind study to volunteers in dosages of 10(7.9) EID50/ml, 10(7.25) EID50/ml, 10(5.7) EID50/ml. The tolerability, safety, and immunogenicity of the vaccine were investigated. No revertant v